One more thought — not sure how MD Anderson ranks in GBM but I assume they’re near the top. Based on my experience reading deeply on cancer treatment options, it’s the best overall of the big four (Sloan Kettering, Dana Farber and Mayo being the other three). MDA is just as up-to-date as the others but it seems to foster out-of-the-box approaches more than the others. Inside-the-box hasn’t worked as well as we would have hoped.
On the other hand, the other three may have something cooking, specific to their institution that they’re looking at that is promising as well.
Obviously general statements from an anonymous poster on a mb — grab salt and sprinkle liberally.
News 
Market Data 
Discover 
